Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Lane

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of the American College Health Association|October 1, 1975
The formation of a student emergency medical services corps at Amherst CollegeJ S Vayer, R M Lane
Cellular and Molecular Neurobiology|May 13, 1999
Chirality and drugs used in psychiatry: nice to know or need to know?R M Lane, G B Baker
International Clinical Psychopharmacology|September 1, 1995
Sertraline 50 mg daily: the optimal dose in the treatment of depressionS H Preskorn, R M Lane
Journal of Clinical Psychopharmacology|February 6, 1999
Effects of SSRIs on sexual function: a critical reviewR C Rosen, R M Lane, M Menza
The British Journal of Clinical Practice|September 1, 1994
Pharmacotherapy of the depressed patient with cardiovascular and/or cerebrovascular illnessR M Lane, M Sweeney, J A Henry
The Physician and Sportsmedicine|July 12, 2016
LettersR M Lane, A L Williams, F H Sillman
Journal of Clinical Periodontology|March 1, 1987
The effects of a dentifrice containing a zinc salt and a non-cationic antimicrobial agent on plaque and gingivitisC A Saxton, R M Lane, F van der Ouderaa
International Clinical Psychopharmacology|October 21, 1999
Predictors of an acute antidepressant response to fluoxetine and sertralineM F Flament, R M Lane, R Zhu, et al.
The Journal of Clinical Psychiatry|December 6, 2000
Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depressionA V Ravindran, J D Guelfi, R M Lane, et al.
International Clinical Psychopharmacology|September 19, 2000
A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depressionJ P Lépine, J Goger, C Blashko, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of the American College Health Association|October 1, 1975
The formation of a student emergency medical services corps at Amherst CollegeJ S Vayer, R M Lane
Cellular and Molecular Neurobiology|May 13, 1999
Chirality and drugs used in psychiatry: nice to know or need to know?R M Lane, G B Baker
International Clinical Psychopharmacology|September 1, 1995
Sertraline 50 mg daily: the optimal dose in the treatment of depressionS H Preskorn, R M Lane
Journal of Clinical Psychopharmacology|February 6, 1999
Effects of SSRIs on sexual function: a critical reviewR C Rosen, R M Lane, M Menza
The British Journal of Clinical Practice|September 1, 1994
Pharmacotherapy of the depressed patient with cardiovascular and/or cerebrovascular illnessR M Lane, M Sweeney, J A Henry
The Physician and Sportsmedicine|July 12, 2016
LettersR M Lane, A L Williams, F H Sillman
Journal of Clinical Periodontology|March 1, 1987
The effects of a dentifrice containing a zinc salt and a non-cationic antimicrobial agent on plaque and gingivitisC A Saxton, R M Lane, F van der Ouderaa
International Clinical Psychopharmacology|October 21, 1999
Predictors of an acute antidepressant response to fluoxetine and sertralineM F Flament, R M Lane, R Zhu, et al.
The Journal of Clinical Psychiatry|December 6, 2000
Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depressionA V Ravindran, J D Guelfi, R M Lane, et al.
International Clinical Psychopharmacology|September 19, 2000
A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depressionJ P Lépine, J Goger, C Blashko, et al.
Pageof 3